This is the authors' abstract. We don't add key points for this paper.
Report the safety, tolerability, and PK findings of oral troriluzole in healthy subjects (HS) from three Phase I studies: BHV4157-101 (first in human, single and multiple dose); BHV4157-103 (multiple-dose) and BHV4157-108 (single escalating doses).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sevinsky et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: